BIOVF
Price
$29.25
Change
+$2.19 (+8.09%)
Updated
Jun 26 closing price
Capitalization
5.81B
BIOYF
Price
$8.63
Change
-$0.05 (-0.58%)
Updated
Jul 1 closing price
Capitalization
66.94M
Interact to see
Advertisement

BIOVF vs BIOYF

Header iconBIOVF vs BIOYF Comparison
Open Charts BIOVF vs BIOYFBanner chart's image
Swedish Orphan Biovitrum AB
Price$29.25
Change+$2.19 (+8.09%)
Volume$235
Capitalization5.81B
BioSyent
Price$8.63
Change-$0.05 (-0.58%)
Volume$1.25K
Capitalization66.94M
BIOVF vs BIOYF Comparison Chart in %
Loading...
BIOVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIOYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIOVF vs. BIOYF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOVF is a Buy and BIOYF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (BIOVF: $29.25 vs. BIOYF: $8.63)
Brand notoriety: BIOVF and BIOYF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BIOVF: 18% vs. BIOYF: 53%
Market capitalization -- BIOVF: $5.81B vs. BIOYF: $66.94M
BIOVF [@Pharmaceuticals: Other] is valued at $5.81B. BIOYF’s [@Pharmaceuticals: Other] market capitalization is $66.94M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIOVF’s FA Score shows that 0 FA rating(s) are green whileBIOYF’s FA Score has 2 green FA rating(s).

  • BIOVF’s FA Score: 0 green, 5 red.
  • BIOYF’s FA Score: 2 green, 3 red.
According to our system of comparison, BIOYF is a better buy in the long-term than BIOVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIOVF’s TA Score shows that 4 TA indicator(s) are bullish while BIOYF’s TA Score has 3 bullish TA indicator(s).

  • BIOVF’s TA Score: 4 bullish, 4 bearish.
  • BIOYF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BIOYF is a better buy in the short-term than BIOVF.

Price Growth

BIOVF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while BIOYF (@Pharmaceuticals: Other) price change was +1.35% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

BIOYF is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIOVF($5.81B) has a higher market cap than BIOYF($66.9M). BIOVF has higher P/E ratio than BIOYF: BIOVF (19.92) vs BIOYF (18.48). BIOYF YTD gains are higher at: 12.856 vs. BIOVF (5.748). BIOVF has higher annual earnings (EBITDA): 6.96B vs. BIOYF (7.42M). BIOVF has more cash in the bank: 790M vs. BIOYF (26.2M). BIOYF has less debt than BIOVF: BIOYF (1.35M) vs BIOVF (28.2B). BIOVF has higher revenues than BIOYF: BIOVF (20.1B) vs BIOYF (27.4M).
BIOVFBIOYFBIOVF / BIOYF
Capitalization5.81B66.9M8,677%
EBITDA6.96B7.42M93,851%
Gain YTD5.74812.85645%
P/E Ratio19.9218.48108%
Revenue20.1B27.4M73,358%
Total Cash790M26.2M3,015%
Total Debt28.2B1.35M2,085,799%
FUNDAMENTALS RATINGS
BIOVF vs BIOYF: Fundamental Ratings
BIOVF
BIOYF
OUTLOOK RATING
1..100
3792
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
31
Undervalued
PROFIT vs RISK RATING
1..100
4924
SMR RATING
1..100
6541
PRICE GROWTH RATING
1..100
5750
P/E GROWTH RATING
1..100
9457
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIOYF's Valuation (31) in the null industry is somewhat better than the same rating for BIOVF (83). This means that BIOYF’s stock grew somewhat faster than BIOVF’s over the last 12 months.

BIOYF's Profit vs Risk Rating (24) in the null industry is in the same range as BIOVF (49). This means that BIOYF’s stock grew similarly to BIOVF’s over the last 12 months.

BIOYF's SMR Rating (41) in the null industry is in the same range as BIOVF (65). This means that BIOYF’s stock grew similarly to BIOVF’s over the last 12 months.

BIOYF's Price Growth Rating (50) in the null industry is in the same range as BIOVF (57). This means that BIOYF’s stock grew similarly to BIOVF’s over the last 12 months.

BIOYF's P/E Growth Rating (57) in the null industry is somewhat better than the same rating for BIOVF (94). This means that BIOYF’s stock grew somewhat faster than BIOVF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOVFBIOYF
RSI
ODDS (%)
Bullish Trend 2 days ago
40%
Bearish Trend 2 days ago
41%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
40%
Bullish Trend 2 days ago
48%
Momentum
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
38%
MACD
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
49%
Bullish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 2 days ago
46%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 2 days ago
46%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
32%
View a ticker or compare two or three
Interact to see
Advertisement
BIOVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIOYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSWV13.210.25
+1.93%
Main Street Financial Services Corp.
PINXY12.38N/A
N/A
Peoples Insurance Company Group China
WRRZF0.02N/A
N/A
WALKER RIV RES CORP
QBCRF30.27N/A
N/A
Quebecor Inc.
COVCF15.27-1.27
-7.68%
COVER CORP.

BIOVF and

Correlation & Price change

A.I.dvisor tells us that BIOVF and INNPF have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIOVF and INNPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOVF
1D Price
Change %
BIOVF100%
N/A
INNPF - BIOVF
20%
Poorly correlated
-99.04%
APNHY - BIOVF
19%
Poorly correlated
+3.27%
BIOGY - BIOVF
11%
Poorly correlated
+5.57%
BOIRF - BIOVF
1%
Poorly correlated
N/A
ARSUF - BIOVF
1%
Poorly correlated
N/A
More

BIOYF and

Correlation & Price change

A.I.dvisor tells us that BIOYF and BUDZ have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIOYF and BUDZ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOYF
1D Price
Change %
BIOYF100%
N/A
BUDZ - BIOYF
6%
Poorly correlated
-2.88%
AVCNF - BIOYF
1%
Poorly correlated
-2.21%
APNHY - BIOYF
0%
Poorly correlated
+3.27%
BSPK - BIOYF
0%
Poorly correlated
N/A
BIOVF - BIOYF
0%
Poorly correlated
N/A
More